ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
GSK's NASH trial HORIZON completes; malaria and myeloma studies stay in viewNov 13Weekly roundup, 5 itemsbelantamab mafodotinGlaxoSmithKlineUpdated
CHMP backs single Bexsero booster dose for ages 10 and upNov 13Regulatory milestonebexseroGlaxoSmithKline
AnaptysBio reports Q1 FY2027 results, Jemperli nears $1 billion in nine-month salesNov 12Regulatory decisionAnaptysBio, Inc.dostarlimab-gxlyUpdated
GSK posts Phase 3b results for Bexsero booster; registers new bioavailability and UC trialsNov 6Weekly roundup, 7 itemsaletekitugbepirovirsenUpdated
GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts resultsOct 30Weekly roundup, 10 itemsaletekitugAmgenUpdated
GSK reports phase Ib data for Mo-Rez in platinum-resistant ovarian cancerOct 26Clinical readoutGlaxoSmithKlinemocertatug rezetecan
FDA approves GSK's Hibsago for chronic hepatitis BOct 20Regulatory decisionbepirovirsenGlaxoSmithKline
Phase II NEO-MEL-T melanoma trial posts results after reaching primary completionOct 20Trial updatecobolimabdostarlimab-gxly
FDA grants accelerated approval to dostarlimab for rectal cancerOct 19Regulatory decisiondostarlimab-gxlyGlaxoSmithKline
GSK registers large new Shingrix cardiovascular trial; DESTINY HES study update postedOct 15Weekly roundup, 4 itemsdepemokimabdostarlimab-gxly
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
New Phase Ib myeloma study registered; GSK-linked FTD trial terminated, BRCA study postedSep 24Weekly roundup, 3 itemsAL001Alector, Inc.
GSK's IPF drug GSK3915393 fails Phase 2 on futility; expanded access opens for velzatinib in GISTSep 18Weekly roundup, 3 itemsGlaxoSmithKlineGSK3915393
GSK registers Phase 3 trials for mRNA flu vaccine and prostate cancer ADC Ris-RezSep 4Weekly roundup, 2 itemsGlaxoSmithKlinerisvutatug rezetecan
GSK posts results for 2021 COVID-19 SAM vaccine trial; advances four Phase 3 respiratory studiesAug 27Weekly roundup, 7 itemsefimosfermin alfaganfeborole
NIAID-led IMPAACT 2026 pharmacokinetic study terminated early, results postedAug 26Trial updateGilead SciencesGlaxoSmithKline